Margetuximab
Product Specifications
CAS Number
1350624-75-7
Target
HER, EGFR
Related Pathways
JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.993
Bioactivity
Margetuximab (MGAH-22) is a second generation anti-human epidermal growth factor receptor 2 protein (HER2) monoclonal antibody with anti-tumor activity for the study of metastatic HER2-positive breast cancer and for the synthesis of nanomedicines.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
428655-01 100 mg
4- (2-Methoxy-4,5-dimethyl-phenyl) -thiazol-2-ylamine
Sign In for Pricing
View Details 428655-02 250 mg
4- (2-Methoxy-4,5-dimethyl-phenyl) -thiazol-2-ylamine
Sign In for Pricing
View Details 
A0906-88L 50 µg
ADRB2 (ADRB2R, ADRBR, B2AR, BAR, Beta-2 Adrenergic Receptor, Beta-2 Adrenoceptor, Beta-2 Adrenoreceptor, BETA2AR , Adrenergic, beta-2-, Receptor, Surface)
Sign In for Pricing
View Details